Patent · US Expired

Pyrrolidine-3,4-dicarboxamide derivatives

US7550487B2 · kind B2 · utility

1Cited by

3References

30Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Lilli Anselm · Binzen, DE
Katrin Groebke Zbinden · Liestal, CH
Wolfgang Haap · Bad Kötzting, DE
Jacques Himber · Guebwiller, FR
Christoph Martin Stahl · Glückstadt, DE
Stefan Thomi · Basel, CH

Key dates

Filing date	Mar 9, 2005
Grant date	Jun 23, 2009
Priority date	—
Expiry date	Mar 21, 2025

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is concerned with novel pyrrolidine-3,4-dicarboxamide derivatives of formula (I)wherein R1 to R9 and X are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.